A MXI1-NUTM1 fusion protein with MYC-like activity suggests a novel oncogenic mechanism in a subset of NUTM1-rearranged tumors

Emerging entities in NUTM1 ‐rearranged neoplasms

(2020) Christopher R. McEvoy et al.   GENES CHROMOSOMES & CANCER

NUTM1-rearranged neoplasia: a multi-institution experience yields novel fusion partners and expands the histologic spectrum

(2019) Todd M. Stevens et al.   MODERN PATHOLOGY

Detecting disease‐defining gene fusions in unclassified round cell sarcomas using anchored multiplex PCR/targeted RNA next‐generation sequencing—Molecular and clinicopathological characterization of 16 cases

(2019) Jose G. Mantilla et al.   GENES CHROMOSOMES & CANCER

CNspector: a web-based tool for visualisation and clinical diagnosis of copy number variation from next generation sequencing

(2019) John F. Markham et al.   Scientific Reports

Sarcoma with MGA–NUTM1 fusion in the lung: an emerging entity

(2019) Taichiro Goto et al.   VIRCHOWS ARCHIV

Improved next-generation sequencing pre-capture library yields and sequencing parameters using on-bead PCR

(2019) Christopher R McEvoy et al.   BIOTECHNIQUES

Ectomesenchymal Chondromyxoid Tumor

(2018) Brendan C. Dickson et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid Tumors

(2018) Jeremy Lewin et al.   JOURNAL OF CLINICAL ONCOLOGY

Novel MXD4-NUTM1 fusion transcript identified in primary ovarian undifferentiated small round cell sarcoma

(2018) Ryo Tamura et al.   GENES CHROMOSOMES & CANCER

NUT Carcinoma: Clinicopathologic features, pathogenesis, and treatment

(2018) Christopher A. French   PATHOLOGY INTERNATIONAL

Salmon provides fast and bias-aware quantification of transcript expression

(2017) Rob Patro et al.   NATURE METHODS

Andy’s Algorithms: new automated digital image analysis pipelines for FIJI

(2017) Andrew M. K. Law et al.   Scientific Reports

Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown

(2016) Mihaela Pertea et al.   Nature Protocols

Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628

(2016) A. Stathis et al.   Cancer Discovery

The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains

(2015) Artyom A. Alekseyenko et al.   GENES & DEVELOPMENT

JAFFA: High sensitivity transcriptome-focused fusion gene detection

(2015) Nadia M Davidson et al.   Genome Medicine

The Molecular Signatures Database Hallmark Gene Set Collection

(2015) Arthur Liberzon et al.   Cell Systems

HTSeq--a Python framework to work with high-throughput sequencing data

(2014) S. Anders et al.   BIOINFORMATICS

Activation of SOX2 Expression by BRD4-NUT Oncogenic Fusion Drives Neoplastic Transformation in NUT Midline Carcinoma

(2014) R. Wang et al.   CANCER RESEARCH

Anchored multiplex PCR for targeted next-generation sequencing

(2014) Zongli Zheng et al.   NATURE MEDICINE

voom: precision weights unlock linear model analysis tools for RNA-seq read counts

(2014) Charity W Law et al.   GENOME BIOLOGY

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples

(2013) Kristian Cibulskis et al.   NATURE BIOTECHNOLOGY

MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma

(2013) A R Grayson et al.   ONCOGENE

Regulation of gene transcription by the oncoprotein MYC

(2011) Bernhard Lüscher et al.   GENE

Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains

(2010) Nicolas Reynoird et al.   EMBO JOURNAL

Diagnosis of NUT Midline Carcinoma Using a NUT-specific Monoclonal Antibody

(2009) Herbert Haack et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

VarScan: variant detection in massively parallel sequencing of individual and pooled samples

(2009) Daniel C. Koboldt et al.   BIOINFORMATICS

Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response

(2008) A. Swarbrick et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA